Skip to main content
. 2020 Jul 20;21(14):5114. doi: 10.3390/ijms21145114

Figure 1.

Figure 1

The major targetable pathways and abnormalities in acute myeloid leukemia (AML). Small molecule drugs targeting mutant genes, small molecule drugs targeting signal pathways, drugs targeting epigenetic regulation, antibody therapy, immune checkpoint inhibitors, and adoptive therapy in AML.